Live Breaking News & Updates on University Hospital Essen

Stay updated with breaking news from University hospital essen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Expert: Combination of Lenvatinib, Pembrolizumab Outperformed Sunitinib in the Treatment of Advanced RCC

Viktor Grunwald, MD, PhD, discusses the post-hoc analysis of the phase 3 CLEAR trial investigating the combination treatment in the first-line setting for advanced renal cell carcinoma. ....

Viktor Grunwald , Axel Kock , European Society Of Medical Oncology , University Hospital Essen , Pharmacy Times , Interdisciplinary Genitourinary Oncology , Medical Oncology ,

PARP Inhibitors, Platinum Chemo Show Comparable Efficacy in BRCA-Positive mCRPC

Platinum chemotherapy is a valid treatment option in patients with BRCA mutations, according to investigators. This is the first analysis to compare efficacy of PARP inhibitors, platinum in BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC). ....

Tibor Szarvas , German Cancer Consortium , University Of Duisburg , University Hospital Essen , European Urology ,

PARP Inhibitors, Platinum Chemo Show Comparable Efficacy in BRCA-Positive mCRPC

Platinum chemotherapy is a valid treatment option in patients with BRCA mutations, according to investigators. This is the first analysis to compare efficacy of PARP inhibitors, platinum in BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC). ....

Tibor Szarvas , University Of Duisburg , German Cancer Consortium , University Hospital Essen , European Urology ,